Assessing potentially inappropriate medication use among older adults in Central and Eastern Europe
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F67985807%3A_____%2F25%3A00642021" target="_blank" >RIV/67985807:_____/25:00642021 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11110/25:10505693 RIV/00216208:11160/25:10505693
Result on the web
<a href="https://doi.org/10.1080/07853890.2025.2579794" target="_blank" >https://doi.org/10.1080/07853890.2025.2579794</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1080/07853890.2025.2579794" target="_blank" >10.1080/07853890.2025.2579794</a>
Alternative languages
Result language
angličtina
Original language name
Assessing potentially inappropriate medication use among older adults in Central and Eastern Europe
Original language description
OBJECTIVE: The aim of this study was to examine the prevalence of potentially inappropriate medication (PIM) use and its associated risk factors in community-dwelling older adults from five Central and Eastern European (CEE) countries. MATERIALS AND METHODS: This secondary analysis of a cross-sectional survey, which was part of the Horizon 2020 EuroAgeism ESR7 project, was conducted between February 2019 and March 2020 in Bulgaria, Croatia, Czechia, Estonia, and Serbia. We enrolled older adults aged ≥665 years who visited community pharmacies to acquire medications. The prevalence of PIM use was determined by applying all 282 criteria from the EU(7)-PIM list. Risk and protective factors for PIM use were evaluated using multiple logistic regression. R software version 4.3.2 was used in statistical analysis. RESULTS: Most of the 2,155 participants were women (63.3%) and aged 65–74 years (64.8%). The overall PIM prevalence was 56.0% (95% confidence interval 53.8%–58.1%), ranging from 29.5% in Czechia to 70.0% in Croatia. The most commonly used PIMs were benzodiazepines (16.7% of all PIMs), followed by nonsteroidal anti-inflammatory drugs (14.3%), and proton pump inhibitors taken for more than 8 weeks (14.1%). Multiple logistic regression revealed that residence, increasing comorbidity burden, and polypharmacy were significant risk factors associated with PIM use in older adults. CONCLUSIONS: Our findings demonstrate a high prevalence of PIM use among older patients from CEE countries and considerable cross-country differences, underscoring the need to improve medication prescribing for older adults to improve healthcare quality and patient outcomes. KEY MESSAGES: Potentially inappropriate medication use is widespread in Central and Eastern Europe. It is necessary to improve the prescribing process for older adults worldwide.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
10103 - Statistics and probability
Result continuities
Project
<a href="/en/project/EH22_008%2F0004607" target="_blank" >EH22_008/0004607: New Technologies for Translational Research in Pharmaceutical Sciences /NETPHARM</a><br>
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2025
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Annals of Medicine
ISSN
0785-3890
e-ISSN
1365-2060
Volume of the periodical
57
Issue of the periodical within the volume
1
Country of publishing house
GB - UNITED KINGDOM
Number of pages
14
Pages from-to
2579794
UT code for WoS article
001607385700001
EID of the result in the Scopus database
2-s2.0-105020774112